Inventor · disambiguated record
Jean-Claude Tardif
Also filed as: TARDIF JEAN-CLAUDE
14 granted patents·19 pending applications·37 citations·filing 1998–2023
89Inventor score
Files withHOFFMANN LA ROCHE7INST DE CARDIOLOGIE DE MONTREAL6DALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH3INST CARDIOLOGIE MONTREAL3TARDIF JEAN-CLAUDE3
Top patents by PatentIndex Score
33 records- 0188US10711303B2CETP inhibitors for therapeutic useHOFFMANN LA ROCHE·Filed 2018·Granted Jul 14, 2020·3 cites·12 claims
- 0285US9909178B2Dalcetrapib for therapeutic useHOFFMANN LA ROCHE·Filed 2015·Granted Mar 6, 2018·5 cites·15 claims
- 0383US11400063B2Early administration of low-dose colchicine after myocardial infarctionINST DE CARDIOLOGIE DE MONTREAL·Filed 2020·Granted Aug 2, 2022·1 cites·50 claims
- 0482US11401554B2Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agentHOFFMANN LA ROCHE·Filed 2020·Granted Aug 2, 2022·1 cites·13 claims
- 0582US10584385B2Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agentHOFFMANN LA ROCHE·Filed 2017·Granted Mar 10, 2020·3 cites·20 claims
- 0677US12371748B2Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agentHOFFMANN LA ROCHE·Filed 2022·Granted Jul 29, 2025·0 cites·12 claims
- 0777US8163699B2Method for the treatment of valvular diseaseTARDIF JEAN-CLAUDE·Filed 2007·Granted Apr 24, 2012·6 cites·16 claims
- 0875US2023364040A1Early administration of low-dose colchicine after myocardial infarctionINST DE CARDIOLOGIE DE MONTREAL·Filed 2023·Application pending·0 cites
- 0974US7993859B2Method for quantifying oxidative stress caused by different biological pathwaysINST CARDIOLOGIE MONTREAL·Filed 2010·Granted Aug 9, 2011·4 cites·2 claims
- 1068US2022249409A1Early administration of low-dose colchicine after myocardial infarctionINST DE CARDIOLOGIE DE MONTREAL·Filed 2022·Application pending·0 cites
- 1167US11549142B2CETP inhibitors for therapeutic useHOFFMANN LA ROCHE·Filed 2020·Granted Jan 10, 2023·0 cites·10 claims
- 1264US11844771B2Methods of treating acute respiratory distress syndrome using colchicineINST DE CARDIOLOGIE DE MONTREAL·Filed 2022·Granted Dec 19, 2023·0 cites·20 claims
- 1364US8030010B2Method for detecting a biomarker of oxidative stress in a biological sampleINST CARDIOLOGIE MONTREAL·Filed 2006·Granted Oct 4, 2011·2 cites·16 claims
- 1456US2014309426A1Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complexINST CARDIOLOGIE MONTREAL·Filed 2014·Application pending·0 cites
- 1556US2018155784A1Cetp inhibitors for therapeutic useHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1655US2021290623A1Methods for treating or preventing cardiovascular disorders and lowering risk of cardiovascular eventsDALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH·Filed 2021·Application pending·0 cites
- 1753US2019070178A1Methods for treating or preventing cardiovascular disorders and lowering risk of cardiovascular eventsDALCOR PHARMA UK LTD STOCKPORT ZUG BRANCH·Filed 2018·Application pending·0 cites
- 1852US2004255959A1Method and compounds to decrease the incidence of atrial fibrillation (AF) in patients with left ventricular dysfunctionFiled 2004·Application pending·0 cites
- 1952US2016230231A1Genotyping tests and methods for evaluating plasma creatine kinase levelsINST DE CARDIOLOGIE DE MONTREAL·Filed 2014·Application pending·0 cites
- 2051US2004259932A1Method and compound to reduce the incidence of diabetes in a subject with chronic heart failureFiled 2004·Application pending·0 cites
- 2151US2020222406A1Methods for treating or preventing cardiovascular disorders and lowering risk of cardiovascular eventsDALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH·Filed 2020·Application pending·0 cites
- 2250US2021236442A1Methods for delaying occurrence of new-onset type 2 diabetes and for slowing progression of and treating type 2 diabetesDALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH·Filed 2021·Application pending·0 cites
- 2349US2011092430A1Method and compound for the treatment of valvular diseaseMONTREAL HEART INST·Filed 2010·Application pending·0 cites
- 2448US6214887B1Vascular remodeling agentQUATRO SCIENT INC·Filed 1998·Granted Apr 10, 2001·12 cites·16 claims
- 2546US2008200450A1Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunctionSERVIER LAB·Filed 2008·Application pending·0 cites
- 2643US2013197226A1Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complexTARDIF JEAN-CLAUDE·Filed 2011·Application pending·0 cites
- 2742US2015374675A1Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complexINST CARDIOLOGIE DE MONTRÉAL·Filed 2015·Application pending·0 cites
- 2840US2012021982A1Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunctionTARDIF JEAN-CLAUDE·Filed 2011·Application pending·0 cites
- 2939US2003181520A1Methods of reversing and preventing cardiovascular pathologiesFiled 2002·Application pending·0 cites
- 3032US2011288072A1Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunctionBENATAR VIDAL·Filed 2011·Application pending·0 cites
- 3129US2003120142A1Method for identification and visualization of atrial tissue and therapeutical use thereofFiled 2002·Application pending·0 cites
- 3228US11840707B2Co-culture system and method for in vitro assessment of reverse cholesterol transportINST DE CARDIOLOGIE DE MONTREAL·Filed 2017·Granted Dec 12, 2023·0 cites·18 claims
- 3316USD1083357SCabinet pill dispenserJCT BIOTECHNOLOGIES INC·Filed 2022·Granted Jul 15, 2025·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Jean-Claude Tardif files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →